TENX - Tenax Therapeutics Inc
Tenax Therapeutics Inc Logo

TENX - Tenax Therapeutics Inc

https://www.tenaxthera.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing, and marketing products for cardiovascular and pulmonary disease in the United States and Canada. The company is headquartered in Morrisville, North Carolina.

52W High
$7.89
52W Low
$3.25
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
1.44
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
2.04
Forward P/E (<15 better)
0.30
EV/EBITDA (<8 favorable)
-0.14
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
0.27
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
0.21%
Institutions (25–75% balanced)
64.83%
Shares Outstanding
4,562,500
Float
4,506,100
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
2.94
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-0.56%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
0.0367
Previous
0.0314
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025